CytoDel (United States)
CytoDel Inc.
CytoDel Inc.'s patented and proprietary technology platform is based on producing recombinant derivatives of botulinum neurotoxin (BoNT) engineered to create high value products with customized properties, and to deliver active agents to therapeutic targets inside neurons.
Company details
- Address
- United States
- Website
- cytodel.com
Reviews
No reviews yet.
Domain and WHOIS record
- Domain
- cytodel.com
- Registrar
- GoDaddy.com, LLC
- Registered
- 11 Oct 2011
- Expires
- 21 Jun 2027
- Record updated
- 22 Jun 2026
- Name servers
- ns1.wix.com, ns2.wix.com
- DNSSEC
- Not signed